January 9, 2014 / 1:07 PM / 4 years ago

BRIEF-U.S.-listed shares of Acasti Pharma up 10.7 percent premarket

NEW YORK, Jan 9 (Reuters) - Acasti Pharma Inc : * U.S.-listed shares of Acasti Pharma up 10.7 percent to $1.55 in premarket after the FDA clears its investigational new drug submission to conduct a pharmacokinetic trial

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below